DATE AND TIME
The webinar has been organised. Register to watch the video.
LANGUAGE AND DURATION
Duration: 30 minutes, followed by questions from the audience
Presenter: Dr Dipak Ram, Consultant Paediatric Neurologist at Royal Manchester Children’s Hospital, United Kingdom
- Reviewing typical MLD disease trajectories and clinical characteristics
- Exploring modelling and treatment approaches available for MLD patients
- Examining the importance of early diagnosis and the early start of treatment
- Understanding the MLD patient and parent journey following the start of treatment
Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. Early-onset clinical manifestations are often overlooked or confused with other conditions causing confusion among non-trained HCPs at first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in starting treatment significantly affect the conditions’ development and the patient’s health and quality of life.
This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Neurologists, and other physicians and healthcare professionals interested in Metabolic Diseases.